NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis Vaccines



Investigators at University of Strasbourg have published new data on tuberculosis vaccines



July 8th, 2008

According to recent research from Strasbourg, France, "Using the example of the anti-tuberculosis vaccine BCG during the 1920s and 1930s, this article asks how a labile laboratory-modified bacteria was transformed into a genuine standard vaccine packaged and commercialized as a pharmaceutical product. At the center of the analysis lies the notion of standardization inquiring why and how a local laboratory process with standard operating procedures (SOPs) reached its limits and was transformed when the product faced international distribution."

"Moving from Paul Ehrlich's initial technological notion of Wertbestimmung referring to a practice physiologically testing the...


Source: TB & Outbreaks Week (2008-07-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login